Nephroceuticals is a leading global manufacturer of scientifically-based nutritional supplements specifically aimed at addressing nutritional deficiencies in patients with Chronic Kidney Disease, Cardiovascular Disease, and Inflammatory Bowel Disease. The company's products adhere to the highest quality standards and FDA certified manufacturing guidelines. Nephroceuticals has established partnerships with world-leading clinical experts and institutions such as the National Kidney Foundation, the American Association of Heart Failure Nurses, and the Crohn’s and Colitis Foundation. Founded in 2010, it operates within the Health Care and Manufacturing industries. Notably, Nephroceuticals received a $1.06M Venture Round investment on February 2, 2012. Although the specific investors behind this round are not disclosed, this funding has likely supported the company's ongoing commitment to cutting-edge research and development in the field of specialized nutritional supplements for patients with critical health conditions.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Venture Round | $1.06M | - | 02 Mar 2012 |
No recent news or press coverage available for Nephroceuticals.